within Pharmacolibrary.Drugs.ATC.S;

model S01GX06
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.4,
    Cl             = 0.016666666666666666,
    adminDuration  = 600,
    adminMass      = 5e-05,
    adminCount     = 1,
    Vd             = 0.0016,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Emedastine is a selective second-generation antihistamine (H1 receptor antagonist) primarily used as ophthalmic drops to treat allergic conjunctivitis. It is approved for topical ocular use and is generally well tolerated, with minimal systemic absorption.</p><h4>Pharmacokinetics</h4><p>Estimate for adults using ophthalmic administration, based on product labeling and nonclinical data. No human compartmental pharmacokinetic models reported in published literature.</p><h4>References</h4><ol></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end S01GX06;
